Hemab Therapeutics (COAG) Fair Value & DCF
COAG$40.48+1.10 +2.79%
Market cap$1.89BEnterprise value$1.39BRevenue (TTM)$0Market position—
Score
70
Bullish
Value
66
Quality
50
Growth
95
Hemab Therapeutics Holdings, Inc. Common Stock (COAG) trades at $40.48 on $1.89B of equity value, with a trailing P/E of -26.58. Fair value on Stocklytics blends discounted cash flow and an earnings-based cross-check when the saved model is on file. The price and ratio here are from the live quote.